| scholarly article | Q13442814 |
| P50 | author | Nicholas S Eyre | Q39999041 |
| Andrew R. Lloyd | Q44958229 | ||
| Rowena A Bull | Q56400255 | ||
| Michael R Beard | Q60601244 | ||
| Karla Helbig | Q61087945 | ||
| Auda A. Eltahla | Q39403960 | ||
| P2093 | author name string | Erin M McCartney | |
| Sumudu K Narayana | |||
| P2860 | cites work | IFITM3 inhibits influenza A virus infection by preventing cytosolic entry | Q21090493 |
| Evolution of vertebrate interferon inducible transmembrane proteins | Q21266712 | ||
| IFITM proteins restrict viral membrane hemifusion | Q21558779 | ||
| Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms | Q24302747 | ||
| IFITM proteins restrict antibody-dependent enhancement of dengue virus infection | Q24311739 | ||
| Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector | Q24316159 | ||
| Molecular analysis of a human interferon-inducible gene family | Q24323277 | ||
| Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus | Q24337838 | ||
| Viperin inhibits hepatitis C virus replication by interfering with binding of NS5A to host protein hVAP-33 | Q24338873 | ||
| ISG56 and IFITM1 proteins inhibit hepatitis C virus replication | Q24339446 | ||
| A diverse range of gene products are effectors of the type I interferon antiviral response | Q24626018 | ||
| Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3 | Q24626267 | ||
| Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation. | Q40560162 | ||
| IFITM1 is a tight junction protein that inhibits hepatitis C virus entry | Q41844055 | ||
| The IFITM proteins inhibit HIV-1 infection | Q24629626 | ||
| The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5A | Q24632380 | ||
| The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus | Q24645420 | ||
| Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus | Q24658111 | ||
| IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion | Q27329190 | ||
| Robust hepatitis C virus infection in vitro | Q27470013 | ||
| Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells | Q27472846 | ||
| Hepatitis C Virus Entry Depends on Clathrin-Mediated Endocytosis | Q27473290 | ||
| Endocytic Rab proteins are required for hepatitis C virus replication complex formation | Q27490939 | ||
| Production of infectious hepatitis C virus in tissue culture from a cloned viral genome | Q27860899 | ||
| Bril: a novel bone-specific modulator of mineralization | Q28580591 | ||
| Phosphorylation of the antiviral protein interferon-inducible transmembrane protein 3 (IFITM3) dually regulates its endocytosis and ubiquitination | Q28588118 | ||
| The N-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization | Q30422163 | ||
| Dynamic imaging of the hepatitis C virus NS5A protein during a productive infection. | Q30576516 | ||
| The SR-BI partner PDZK1 facilitates hepatitis C virus entry. | Q33719403 | ||
| Identification of an endocytic signal essential for the antiviral action of IFITM3. | Q33784795 | ||
| Integrative functional genomics of hepatitis C virus infection identifies host dependencies in complete viral replication cycle | Q33893794 | ||
| A functional genomic screen reveals novel host genes that mediate interferon-alpha's effects against hepatitis C virus | Q34010288 | ||
| Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections | Q34046037 | ||
| The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry | Q34340346 | ||
| S-palmitoylation and ubiquitination differentially regulate interferon-induced transmembrane protein 3 (IFITM3)-mediated resistance to influenza virus | Q36003903 | ||
| Hepatitis C virus infection modulates expression of interferon stimulatory gene IFITM1 by upregulating miR-130A. | Q36246282 | ||
| The CD225 domain of IFITM3 is required for both IFITM protein association and inhibition of influenza A virus and dengue virus replication | Q36978590 | ||
| Global control of hepatitis C: where challenge meets opportunity | Q37077112 | ||
| Principles of lysosomal membrane degradation: Cellular topology and biochemistry of lysosomal lipid degradation | Q37327802 | ||
| The small interferon-induced transmembrane genes and proteins | Q37821933 | ||
| Antiviral resistance and direct-acting antiviral agents for HCV. | Q38063185 | ||
| What does S-palmitoylation do to membrane proteins? | Q38095680 | ||
| Virology and cell biology of the hepatitis C virus life cycle: an update | Q38274457 | ||
| IFITM-Family Proteins: The Cell's First Line of Antiviral Defense | Q38323041 | ||
| Signal transducer and activator of transcription 3 is a proviral host factor for hepatitis C virus. | Q39148017 | ||
| Characteristics of IFITM, the newly identified IFN-inducible anti-HIV-1 family proteins. | Q39200590 | ||
| P433 | issue | 43 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatitis C | Q154869 |
| transmembrane protein | Q424204 | ||
| Hepatitis C virus | Q708693 | ||
| P304 | page(s) | 25946-25959 | |
| P577 | publication date | 2015-09-09 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | The Interferon-induced Transmembrane Proteins, IFITM1, IFITM2, and IFITM3 Inhibit Hepatitis C Virus Entry | |
| P478 | volume | 290 |
| Q52430897 | A CRISPR screen for factors regulating SAMHD1 degradation identifies IFITMs as potent inhibitors of lentiviral particle delivery. |
| Q58596596 | A scorpion venom peptide Ev37 restricts viral late entry by alkalizing acidic organelles |
| Q92527731 | Analysis of IFITM-IFITM Interactions by a Flow Cytometry-Based FRET Assay |
| Q38635092 | Analysis of tick-borne encephalitis virus-induced host responses in human cells of neuronal origin and interferon-mediated protection |
| Q63246712 | Antiviral Protection by IFITM3 In Vivo |
| Q63246519 | Antiviral Role of IFITM Proteins in Classical Swine Fever Virus Infection |
| Q47094466 | Characterization and anti-inflammation role of swine IFITM3 gene |
| Q64374802 | Construction, expression and antiviral activity analysis of recombinant adenovirus expressing human IFITM3 in vitro |
| Q30276614 | Distinct Roles for Intracellular and Extracellular Lipids in Hepatitis C Virus Infection |
| Q91364086 | Exosomal Interferon-Induced Transmembrane Protein 2 Transmitted to Dendritic Cells Inhibits Interferon Alpha Pathway Activation and Blocks Anti-Hepatitis B Virus Efficacy of Exogenous Interferon Alpha |
| Q64989066 | Functional Involvement of Interferon-Inducible Transmembrane Proteins in Antiviral Immunity. |
| Q57792998 | Functional mapping of regions involved in the negative imprinting of virion particles infectivity and in target cell protection by the Interferon-Induced Transmembrane Protein 3 (IFITM3) against HIV-1 |
| Q96343106 | Grouper interferon-induced transmembrane protein 3 (IFITM3) inhibits the infectivity of iridovirus and nodavirus by restricting viral entry |
| Q26775018 | Hepatitis C virus infection and thyroid autoimmune disorders: A model of interactions between the host and the environment |
| Q112052444 | IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro |
| Q59352250 | IFITM1 expression is crucial to gammaherpesvirus infection, in vivo |
| Q38707618 | IFITM1 suppression blocks proliferation and invasion of aromatase inhibitor-resistant breast cancer in vivo by JAK/STAT-mediated induction of p21. |
| Q92855169 | IFITM3 Clusters on Virus Containing Endosomes and Lysosomes Early in the Influenza A Infection of Human Airway Epithelial Cells |
| Q91045937 | IFITM3 directly engages and shuttles incoming virus particles to lysosomes |
| Q38156590 | IFITM3 requires an amphipathic helix for antiviral activity. |
| Q55256172 | Identification of key genes and pathways in regulating immune‑induced diseases of dendritic cells by bioinformatic analysis. |
| Q92028460 | Integrated Transcriptomic and Proteomic Analysis of Red Blood Cells from Rainbow Trout Challenged with VHSV Point Towards Novel Immunomodulant Targets |
| Q41928655 | Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs |
| Q62898063 | Interferon-Induced Transmembrane Protein 1 Restricts Replication of Viruses That Enter Cells via the Plasma Membrane |
| Q91813039 | Interferon-Induced Transmembrane Proteins Mediate Viral Evasion in Acute and Chronic Hepatitis C Virus Infection |
| Q90580146 | Intrahepatic Viral Kinetics during Direct-Acting Antivirals for Hepatitis C in HIV Co-infection:The ACTG A5335S Substudy |
| Q42369135 | Long Non-coding RNAs in Hepatitis C Virus-Infected Cells. |
| Q28834348 | Mass-tag labeling reveals site-specific and endogenous levels of protein S-fatty acylation |
| Q46197224 | More than meets the I: the diverse antiviral and cellular functions of interferon-induced transmembrane proteins |
| Q30145642 | Pediatric Drug Nitazoxanide: A Potential Choice for Control of Zika |
| Q61815883 | Rapid interferon independent expression of IFITM3 following T cell activation protects cells from influenza virus infection |
| Q30361340 | Rhesus macaque IFITM3 gene polymorphisms and SIV infection. |
| Q98664289 | S-palmitoylation of swine interferon-inducible transmembrane protein is essential for its anti-JEV activity |
| Q40958940 | S100A6 Regulates Endothelial Cell Cycle Progression by Attenuating Antiproliferative Signal Transducers and Activators of Transcription 1 Signaling |
| Q47546996 | SMARCA2-regulated host cell factors are required for MxA restriction of influenza A viruses |
| Q97692496 | Single-cell transcriptomic analysis in a mouse model deciphers cell transition states in the multistep development of esophageal cancer |
| Q27928046 | Solute Carrier NTCP Regulates Innate Antiviral Immune Responses Targeting Hepatitis C Virus Infection of Hepatocytes |
| Q90567199 | Ste24: An Integral Membrane Protein Zinc Metalloprotease with Provocative Structure and Emergent Biology |
| Q52367862 | The Host Restriction Factor Interferon-Inducible Transmembrane Protein 3 Inhibits Vaccinia Virus Infection. |
| Q37252899 | The Interferon-Stimulated Gene IFITM3 Restricts Infection and Pathogenesis of Arthritogenic and Encephalitic Alphaviruses |
| Q92879297 | The effects of IFITM1 and IFITM3 gene deletion on IFNγ stimulated protein synthesis |
| Q57106448 | The functional role of sodium taurocholate cotransporting polypeptide NTCP in the life cycle of hepatitis B, C and D viruses |
| Q47592878 | The palmitoyltransferase ZDHHC20 enhances interferon-induced transmembrane protein 3 (IFITM3) palmitoylation and antiviral activity |
| Q90393978 | Topology, Antiviral Functional Residues and Mechanism of IFITM1 |
| Q89840861 | Type 1 Interferon Responses Underlie Tumor-Selective Replication of Oncolytic Measles Virus |
| Q33860964 | Viperin is an important host restriction factor in control of Zika virus infection |
| Q47099548 | miRNA-36 inhibits KSHV, EBV, HSV-2 infection of cells via stifling expression of interferon induced transmembrane protein 1 (IFITM1). |
Search more.